Nippon India Nifty Pharma ETF

Name: Nippon India Nifty Pharma ETF
Brand: Nippon India Mutual Fund

Invest Online Fund Card

Value Research Rating

Unrated

Our Opinion

Riskometer

Very High

₹23.2214 0.15%

As on 18-Mar-2026

Returns

Calculate SIP Returns of Nippon India Nifty Pharma ETF

Upfront Investment

Monthly SIP Amount

Investment Duration

More Details about Returns

Risk

This fund has Very High risk.

Low

Low to Moderate

Moderate

Moderately High

High

Very High

As per SEBI's Riskometer.

More Details about Risk

Portfolio of Nippon India Nifty Pharma ETF

Asset Allocation

Market Cap Weightage

We have shifted from our proprietary CapRank classification system to SEBI’s market cap classification system with effect from 14 Jan, 2026.

Portfolio Breakdown

Peer Comparison

Fund name	Rating	Risk		Expense Ratio (%)
Nippon India Nifty Pharma ETF	Unrated	Very High	loading...	0.21
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Invest Now		Very High	loading...	1.86
SBI Healthcare Opportunities Fund Invest Online		Very High	loading...	1.93
UTI Healthcare Fund - Regular Plan Invest Online		Very High	loading...	2.27
Nippon India Pharma Fund Invest Online		Very High	loading...	1.81

Detailed Comparison

Other details of Nippon India Nifty Pharma ETF

Assets

₹1,059 Cr

Exit Load (Days)

Min. Investment (₹)

1,000

Min. Withdrawal (₹)

Min. SIP Investment (₹)

Min. No of Cheques

More Details

About Nippon India Nifty Pharma ETF

Nippon India Nifty Pharma ETF is a equity mutual fund scheme of Nippon India Mutual Fund. Launched on July 02, 2021, it is currently managed by Jitendra Tolani. The fund has an expense ratio of 0.21% with an overall AUM (Assets Under Management) of ₹1,059 Cr.

Nippon India Nifty Pharma ETF is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. Being passively managed, it replicates the portfolio of its chosen benchmark index. The fund allows minimum lumpsum investment of ₹-- and minimum SIP of ₹--.

Investment Strategy

The scheme seeks to provide investment returns closely corresponding to the total returns of the securities as represented by the NIFTY Pharma Index before expenses, subject to tracking errors.

Suitability

Nobody should invest in Pharma funds in our opinion, because:

They have a narrow focus on only pharmaceutical and healthcare companies
Instead, diversified equity funds which invest across sectors are better

If you still choose to invest:

Invest only through SIP
Have a 7+ year investment horizon
Be prepared to withstand interim sharp declines in investment value
Being passively managed, the fund replicates the portfolio of its chosen benchmark index

Capital Gains Taxation

If the mutual fund units are sold after 1 year from the date of investment, gains upto Rs 1.25 lakh in a financial year are exempt from tax. Gains over Rs 1.25 lakh are taxed at the rate of 12.5%.
If the mutual fund units are sold within 1 year from the date of investment, entire amount of gain is taxed at the rate of 20%.
No tax is to be paid as long as you continue to hold the units.

Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.

Dividend Taxation

Dividends are added to the income of the investors and taxed according to their respective tax slabs. Further, if an investor's dividend income exceeds Rs. 10,000 in a financial year, the fund house also deducts a TDS of 10% before distributing the dividend.

Latest news on Nippon India Nifty Pharma ETF

Fund manager changes in a few passive schemes of Nippon India Mutual Fund

1 min read•By News Desk

Mehul Dama ceases to be the Fund Manager of Nippon India Mutual Fund

1 min read•By News Desk

All News

Portfolio Planner

Ready-to-go investment options matched to different needs

Fund Screener

Filter for funds based on your criteria.

Fund Compare

Detailed comparison of up to 5 funds across various metrics.

Mutual Fund Calculator

Find out the SIP returns of any fund for any time period.

Best Mutual Funds

List of funds rated highly by Value Research.

SIP Calculator

Calculate how much you can accumulate with your monthly savings.

See All Tools

FAQ for Nippon India Nifty Pharma ETF

How to Invest in Nippon India Nifty Pharma ETF?

To invest in Nippon India Nifty Pharma ETF you need a demat account and a trading account with a stockbroker, as Exchange Traded Funds (ETFs) are bought and sold on the stock exchange just like shares. You can purchase Nippon India Nifty Pharma ETF directly through your broker’s platform.

What is the current NAV of Nippon India Nifty Pharma ETF Today?

The latest declared NAV of Nippon India Nifty Pharma ETF, is ₹23.2214 as of 19-Mar-2026.

What are the top holdings of Nippon India Nifty Pharma ETF?

Company	Percentage of Portfolio
Sun Pharmaceutical	21.93
Divi's Lab	9.71
Dr. Reddy'S Labs	9.35
Cipla	9.04
Lupin	6.65

What is the return of Nippon India Nifty Pharma ETF in the last 5 years?

Over the past five years, Nippon India Nifty Pharma ETF has delivered an annualised return of --% as of 19-Mar-2026.

What is the minimum investment required in Nippon India Nifty Pharma ETF?

The minimum investment required to start investing in Nippon India Nifty Pharma ETF is ₹1,000 for the lump sum option and ₹-- for the SIP (Systematic Investment Plan) option.